FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays
After years of regulatory delays, the U.S. Food and Drug Administration (FDA) has approved Phase 2 of a clinical trial to assess the efficacy of smoked medical cannabis in treating post-traumatic stress disorder (PTSD) among military veterans.
Funded by Michigan’s Veteran Marijuana Research Grant Program, the study is poised to be a critical step in understanding how cannabis impacts PTSD symptoms, Marijuana Moment reported.
See Also: Healing Heroes: Planet 13’s Initiative For Florida Veterans And First Responders
The trial, spearheaded by the Multidisciplinary Association for Psychedelic Studies (MAPS), will be a randomized, placebo-controlled investigation involving 320 veterans diagnosed with moderate to severe PTSD.
Participants will self-titrate doses of high-THC cannabis flower or a placebo, …